Familial Amyloid Polyneuropathy News
Recent Posts
- ART001 gene editor named orphan drug for ATTR amyloidosis
- Amvuttra approved in US to treat adults with ATTR-CM
- Eplontersen approved as Wainzua in EU to treat adults with FAP
- Connecting with amyloidosis patients and caregivers in N.Z.
- Alnylam gearing up for Phase 3 trial of nucresiran in FAP late this year